Introduction
Hepatocellular carcinoma (HCC) is the fifth frequent malignancy worldwide and ranks as the third leading cause of cancer-related mortality 1 . In China, HCC accounts for more than 300,000 deaths every year 2 . In early-stage disease, HCC patients' survival can be significantly improved by treatment including surgical resection and liver transplant. However, HCC mostly exhibits no symptom at early stages. Consequently, less than one third of newly diagnosed HCC patients are eligible for potential curative therapies. Therefore, early diagnosis of HCC is vital for patient survival, and the identification of biomarkers for early HCC detection is a crucial clinical need 3 .
Currently three FDA approved serum biomarkers are recommended to indicate the risk of liver cancer in high risk populations: α-fetoprotein (AFP), AFP-L3, which is a fucosylated isoform of AFP, and des-gamma-carboxy-prothrombin (DCP) 4 . However, these markers are not included in the surveillance guidelines published by the American Association for the Study of Liver Diseases 5 and the European Association for the Study of the Liver 6 because of low sensitivity and specificity. In China, AFP is used jointly with ultrasonography, computed tomography (CT) and pathology examination for early screening of HCC patients, as recommended by the Asian Pacific Association for the Study of the Liver 7 . This is based on the knowledge that the positive rate of AFP in HCC is about 60-80% 8 .
Better biomarkers are needed for HCC. The search for HCC biomarkers from clinical specimens using proteomics approaches has been focused mainly on blood samples 9, 10 . Besides, some studies also investigated biological fluids including urine 11 and tissue interstitial fluid 12 .
Nevertheless, HCC tissue samples have not been extensively studied by advanced proteomics methods, even though dysregulated tissue proteins are presumably the main source of potential blood and biofluidic biomarkers. From the literature, we found that Li, et al studied malignant
and matched non-tumorous tissues (about 100 mg tissue per sample) from eleven HCC patients using two dimensional LC coupled with shotgun proteomics with a LC gradient of 165 min and observed upregulation of SET Complex proteins 13 . Megger, et al nominated 51 differentially expressed proteins from about 573 proteins identified by 2D gel electrophoresis and label-free shotgun proteomic analysis of 7 pairs of HCC tissue samples, 14 . In a more recent study, 
PCT-assisted sample preparation
For each sample, about 1.6 ~ 2.5 mg (wet weight) of frozen tissue was processed based on the protocol described previously 17, 18 . Briefly, tissues were lysed with the PCT-MicroPestle 
SWATH-MS
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The sample samples were spiked with iRT peptides (Biognosis, Zurich, Switzerland) at a 1:10 (vol/vol) ratio. One microgram of peptide sample was injected to an Eksigent 1D+ Nano LC systems (Eksigent, Dublin, CA) and analyzed in a 5600 TripleTOF mass spectrometer (SCIEX) in SWATH mode as described previously 17 . We optimized the LC gradient to 45 min ( Supplementary Fig. 1 ), and the SWATH acquisition scheme to 67 variable windows (Supplementary Table 1 ). The other SWATH parameters were set exactly as in our previous study 17 , except that the ion accumulation time for each SWATH window was 40 ms. Ion accumulation time for peptide precursors was set at 50ms. The 38 samples were injected into the mass spec in randomized sequence once and then the same sequence was injected again to obtain a duplicate analysis. After each gradient, the column was washed twice using ramping gradient to minimize carry-over ( Supplementary Fig. 1 ). Mass calibration using beta-gal was performed every fourth injection.
OpenSWATH analysis
OpenSWATH (version 2014-12-01-154112) 22 was performed as described previously 17 except that a pan-human library (32 windows version) 21 was used to search the SWATH data in the iPortal platform 23 . The details of the pan-human library, containing 139,449 peptides from 10,316 proteins, have been described previously 21 . The default parameters as used previously 17 are provided in Supplementary Table 2 .
Pathway and process enrichment analysis
Pathway and process enrichment analysis of the differentially abundant proteins were performed using Metascape (http://metascape.org). Terms with p-value < 0.01, minimum count 3, and enrichment factor > 1.5 (enrichment factor is the ratio between observed count and the count expected by chance) are collected and grouped into clusters based on their membership similarities. To further capture the relationship among terms, a subset of enriched terms was selected and rendered as a network plot, where terms with similarity > 0.3 are connected by edges.
Protein-protein interaction enrichment analysis was carried out for each given gene list biological process enrichment analysis was applied to each MCODE components independently and the three best-scoring (by p-value) terms were retained as the functional description of the corresponding components.
Statistics
In volcano plots, paired Student t test was used to compute p values followed by Benjamini & Hochberg correction in R.
Data deposition
All the SWATH Data files, library and original OpenSWATH results are deposited in PRIDE project 25 : PXD004873. Reviewer account details: Username:
reviewer82662@ebi.ac.uk; Password: WTpBL22V
(Note for reviewers: Prior to publication, this data set only be found in PRIDE after the reviewer logs into PRIDE using the username and password provided above. This data set cannot be found without logging in.)
Results and Discussion
Identification of peptides and proteins by PCT-SWATH
To start we extracted proteins from 38 biopsy-level liver tissue samples and produced tryptic peptides using the PCT method 17, 26 . We measured the wet weight of each tissue sample and the total amount of peptide mass generated from the tissue and computed the peptide yield in Each peptide sample was then analyzed using SWATH-MS in technical duplicate, using a 45-min LC gradient and a 67 variable SWATH window acquisition scheme (Supplementary Table 1 ) which was optimized based on the ion density map of human proteins extracted from HCC tissues. With this SWATH window setting, up to 20 samples were analyzed per MS instrument per 24 hours. Mass calibration using beta-gal was performed every fourth injection.
The MS analysis of the 76 SWATH runs were completed in about 4 working days.
After searching the resulting raw data files against the pan-human SWATH assay library 21 , 2,579 unique proteotypic SwissProt proteins with 11,787 unique peptides were identified at a false discovery rate (FDR) below 1% using OpenSWATH 21 (Supplementary Table 3 ).
Comparable numbers of proteins and peptides were quantified from both non-tumorous and tumorous type of tissue samples ( Fig. 2A and 2B ). In this study, the PCT-SWATH throughput was further increased compared to the previous work 17 . The protein numbers identified per sample was slightly higher than those obtained from human kidney tissues 17 .
Variability of protein expression between tumor and non-tumorous tissues
To evaluate the quantitative accuracy of the method, we computed the global Pearson correlation of the two technical replicates at the peptide level for all samples after removing missing values. The R 2 was 0.9729 ( Fig. 2C) , indicating that our label-free method could quantify peptides with high degree of reproducibility. The global view of protein quantification is shown in Fig. 2D . It shows that all the technical replicates were clustered together respectively.
We then analyzed the overall variation of protein abundance for all 2,579 quantified proteins from tumor tissues, adjacent non-tumorous (normal) tissues and all samples, respectively (Fig. 3A) . The data showed that the CV of tumorous tissue samples was slightly greater than that of adjacent non-tumorous tissues, indicating more overall variability of protein expression in tumors. We next checked the relationship between protein abundance and the overall variation among these samples and observed that low abundance proteins exhibited a higher degree of overall variability (Fig. 3B, 3C, 3D ). In Fig. 2C , proteins of low abundance demonstrated comparable reproducibility with high abundance proteins, therefore we mainly attributed the higher variability in tumor tissue to biological causes.
Differentially regulated proteins characterized in the HCC cohort
We further explored differentially expressed proteins between tumorous and nontumorous samples. A total of 541 proteins showed significant differential abundance (Fig. 4A ).
Of these, 381 proteins showed increased abundance and 160 proteins showed decreased abundance in tumorous tissues compared to non-tumorous tissues. Pathway enrichment analysis of the regulated proteins in HCC tumorous tissues was performed by Metascape. We found that proteins with increased abundance were highly enriched in mRNA related processes including mRNA metabolic process, peptide metabolic process, ribonucleoprotein complex biogenesis, and nuclear transport. The proteins with decreased abundance were found to be mostly involved in small molecule metabolic processes such as small molecule catabolic process, monocarboxylic acid metabolic process, and carbon metabolism.
Next, we carried out protein-protein interaction network analysis using Metascape. The resultant network contains the subset of proteins that form physical interactions with at least another protein showing altered abundance. Heat shock proteins (HSP) were found to be increased (Fig. 4B) . HSP proteins constitute a family of highly conserved stress response proteins that can protect cells and induce them to repair damage caused by a variety of stress 27 .
Several members of the HSP family have been reported to be overexpressed in a wide range of human cancers 28 . The HSP70 family contains at least eight homologous chaperone proteins that differ from each other by amino acid sequence, expression level and sub-cellular localization 29 .
Hsp70-1 is an essential molecular chaperon upregulated in response to heat, stress, or cell survival protection and its function is tightly controlled by heat shock factor-1 (HSF-1). It has been demonstrated that 14-3-3σ protein induces HSP70 via a β-catenin/HSF-1-dependent pathway, which consequentially modulates HCC. The HSF-1/Hsp70-1 protein complex is therefore considered to be targeted for developing a prognostic tool for HCC 30 .
We also observed that proteins related to mitochondrial translation, specifically the mitochondrial ribosomal proteins (MRPs), were among the most strongly upregulated protein clusters (Fig. 4C) . Tumor initiation and progression in cancer cells involve the development of mechanisms to inhibit apoptosis at multiple stages, whereas mitochondria play crucial roles in the induction of apoptosis and programmed cell death. This paradigm is central to malignant cellular transformation because altered mitochondrial function and defective apoptosis are wellknown hallmarks of cancer cells. It has also been reported that the expression of genes encoding MRPs, mitoribosome assembly factors and mitochondrial translation factors is modulated in multiple cancers, which is linked to tumorigenesis and metastasis 31 . Mini-chromosome maintenance complex component 7 (MCM7) was also found to be overexpressed (Fig. 4C ).
MCM7 plays an essential role in initiating DNA replication. DNA replication is a central process in cell proliferation, while aberrant DNA replication is a driving force of oncogenesis. It has been reported that overexpressed MCM7 is associated with a poor prognosis of HCC patients, and MCM7 promotes HCC cell proliferation via upregulating MAPK-cyclin D1 pathway both in vitro and in vivo 32 . In addition, the hallmark MYC targets proteins, and the cell cycle checkpoint proteins involved in G2/M transitions, are also among the upregulated protein networks.
Small molecule catabolic processes define the group of proteins that showed the strongest reduction of abundance in the HCC samples tested (Fig. 4D) . Our data showed that proteins involved in glycogen metabolism pathway were suppressed in HCC samples. These proteins include the glycogen synthesis enzymes including phosphoglucomutase-1 (PGM1), and UTPglucose-1-phosphate uridylyltransferase (UGP2), as well as the glycogen degradation enzyme liver glycogen phosphorylase (PYGL). They are downregulated in tumorous tissues compared to their matched non-tumorous controls, indicating the reprogramming of glycogen metabolism in HCC which suppresses the turn-over of glycogen. However, our data did not indicate whether this reprogramming changed the direction of glycogen storage.
Both cystathionine β-synthase (CBS) and cystathionine-γ-lyase (CTH) were found at decreased abundance in the HCC samples tested (Fig. 4D ). CBS and CTH are abundant proteins in the liver, endogenously produce hydrogen sulfide (H2S), a gasotransmitter modulating synaptic transmission, vasorelaxation, angiogenesis, inflammation, and cellular bioenergetics.
Regulation of H2S influences lipid metabolism, glucose metabolism, oxidative stress, and mitochondrial bioenergetics 33 . Suppression of CBS transcripts has been reported in a study of 120 HCC patients compared to non-cancerous liver tissue 34 . Reduced CBS transcripts expression is significantly correlated with high tumor stage, high Edmondson grade, and high AFP level 34 . However, neither the CBS nor the CTH protein level has yet been investigated in HCC tissue. Our data suggests downregulation of H2S production via suppressing CBS and CTH in HCC tissues.
The ethanol metabolism was also found to be downregulated (Fig. 4D ). Aldehyde dehydrogenase (ALDH) is a gene superfamily that is responsible for the detoxification of biogenic and xenogenic aldehydes. Both ALDH2 and ALDH1B1 proteins were significantly downregulated. The ethanol detoxifying pathway in humans occurs mainly in the liver and is carried out by two enzymatic steps. In the first step ethanol is metabolized quickly by alcohol dehydrogenase (ADH) to generate acetaldehyde, and the latter is then metabolized by the mitochondrial ALDH2 to acetate 35 . ALDH2 is expressed ubiquitously in all tissues but is most abundant in the liver and found in high amounts in organs that require high mitochondrial oxidative phosphorylation. The downregulation of ALDH in tumorous liver tissue will likely accumulate toxin acetaldehyde and promote tumorigenesis.
In summary, liver is the pivotal organ for molecular synthesis and the metabolic hub of human beings. Our data show that the molecular synthesis related pathways are enhanced, while most major metabolic processes were suppressed in the HCC tissues tested, suggesting a biochemical imbalance in HCC cells.
Proteins with altered abundance in HCC patients with high serum AFP
Next, we explored the molecular pathogenesis of HCC by associating protein expression with various clinic-pathological characteristics of HCC. AFP is the most widely used tumor biomarker currently available for early detection of HCC, and the widely accepted threshold of serum AFP is 20 ng/mL. It has been reported that at this threshold, serum AFP had a sensitivity of 41-65% and specificity of 80-94% 36 . We grouped the 19 HCC patients in our cohort into two groups, according to an AFP-cutoff of 20 ng/mL (Table 1) , computed the fold change of protein expression between tumorous and non-tumorous tissues, and checked the protein regulation pattern of 11 patients with high AFP level (> 20 ng/ml) and six patients with low AFP level (< 20 ng/ml), respectively. Two patients without serum AFP examination value at surgical operation were excluded from these analyses. Although a considerable proportion of HCC patients in the cohort do not have elevated serum AFP, and serum AFP can increase in patients with diseases other than HCC 4 , high expression of AFP in serum correlated with high cell proliferation, high angiogenesis and low apoptosis and was associated with poor prognosis of HCC patients 37 . Indeed, we found in our data set that the low serum AFP level was closely related to higher survival rate of the patients (5 out of 7 patients have recurrence free survival), especially when there was no portal vein thrombosis detected by CT at diagnosis, as is shown in Table 1 . On the other hand, in the AFP-high patient group, 5 of 10 patients were dead and 2 patients suffered from tumor recurrence, displaying poorer survival (Table 1) . Nevertheless, statistical analysis was not feasible due to small sample size.
With respect to the AFP-high patient group, 419 proteins showed increased abundance and 192 proteins showed decreased abundance (P value < 0.05) in tumorous samples compared non-tumorous samples. Pathway enrichment and network analysis of these differentially expressed proteins revealed similar results with the above 541 regulated proteins from all 19 HCC patients (Fig. 5A ). In the AFP-low subgroup, our data showed no protein significantly regulated between the tumorous and non-tumorous tissues, probably due to the small sample size.
In the AFP-high subgroup (Fig. 5B) , we identified additional downregulated proteins including methylene tetrahydrofolate dehydrogenase 1 (MTHFD1), which is an enzyme identified in the one-carbon (1C) metabolism pathway. Another enzyme in the pathway, i.e.
serine hydroxymethyltransferase (SHMT1), is also downregulated (Fig. 4D) . The data suggest reprogramming of one-carbon metabolism in HCC. This is consistent with the Liverome study reporting that downregulation of MTHFD1 is prevalent in proliferative and poorly differentiated HCCs 38 .
We also observed downregulation of a tumor suppressor protein regucalcin (RGN) which modulates multiple protein kinases and phosphatases in cancers including HCC 39 . Transcripts analysis reports that prolonged survival in HCC patients is associated with increased RGN gene expression 40 . Our data at protein level further consolidate the potential roles of RGN in HCC.
Two proteins involved in lipid metabolism showed decreased expression in the AFP-high HCC tissues. ACAA2 is a mitochondrial enzyme involved in the fatty acid metabolism pathway.
ANXA6 is a lipid-binding protein highly expressed in the liver, regulating cholesterol homeostasis and signaling pathways with a role in liver physiology. A recent study found that ANXA6 was downregulated in HCC tissues compared to non-tumorous tissues in 18 HCC patients 41 . The data indicate dysfunction of lipid metabolism in HCC tissues.
Quantitative proteomics analysis of Hepatitis B virus positive (HBV + ) HCC subgroup
Chronic HBV is the most common cause of HCC in China. Approximately 80% of HCC develops from liver cirrhosis, which predominantly progresses from HBV in China 42 . We found that 106 and 75 proteins showed increased or decreased abundance, respectively, in 11 HCC patients with HBV infection (Fig. 5C ) compared to those without HBV infection. Subsequent pathway and protein interaction analysis by Metascape revealed a number of interesting protein clusters (Fig. 5D ) that showed a close relationship to liver cirrhosis in patients with chronic HBV infection. Pyruvate kinase M (PKM) was found to be upregulated in this HBV + subgroup (Fig.   5D ). PKM is a protein kinase that catalyzes the final step in glycolysis by transferring the phosphate from phosphoenolpyruvate (PEP) to ADP, thereby generating pyruvate and ATP 43 .
PKM has two isoforms, PKM1 and PKM2. PKM2 plays an important role in metabolic alterations related to inflammation and cancer. The ATP generation by PKM2, unlike mitochondrial respiration, is independent of oxygen and thus allows tumor cells to grow in hypoxic conditions. Cancer cells are characterized by high glycolytic rates to support energy regeneration and anabolic metabolism, along with the high expression of PKM2 44 . It has been shown in a recent report that the anti-apoptotic protein poly(ADP-ribose) polymerase (PARP)14
promotes aerobic glycolysis in HCC by maintaining low activity of PKM2, and that the PARP14-JNK1-PKM2 regulatory axis links apoptosis and metabolism 45 . In agreement with our finding that HBV + tumors expressed higher level of PKM, there is another report showing that high PKM2 expression was more frequently found in cirrhotic liver caused by HBV infection than in non-cirrhotic liver, and that PKM2 overexpression was associated with poor survival rates in HCC patients with cirrhotic liver (CL) 46 .
Cytidine triphosphate synthase 1 (CTPS1) is another example of a protein that showed higher expression in the HBV + HCC subgroup in this study compared to patients without HBV infection (Fig. 5D) . CTPS1 catalyzes the rate-limiting step in the de novo CTP synthetic pathway, in which a UTP is converted into CTP with the consumption of glutamine and ATP. In fact, upregulated CTPS1 activity has been observed in multiple human and rodent tumors 47 ,
promoting tumor transformation and progression 48 . Recently, researchers focus on the CTPS cytoophidium that is a filamentous intracellular macrostructure aggregated by CTPS, and is able to promote the activity of CTPS 49 . A recent study examined the presence of CTPS cytoophidia in the tumorous and the adjacent non-tumorous tissues of HCC patients, and found that many cytoophidia were observed in 28% of the HCC tumor samples but not the adjacent hepatocyte population 50 . In addition, they found that the high expression of HSP90 was correlated with the presence of CTPS cytoophidia, which is consistent to our findings that heat shock proteins (HSPA1L and HSPA8) and CTPS1 are all upregulated.
Fructose-bisphosphate aldolase B (ALDOB) is an enzyme for glucose and fructose metabolism. In a cohort of 313 HCC patients, ALDOB was found downregulated in HCC tissue using tissue microarray and immunohistochemistry (IHC) technologies, and its downregulation was significantly correlated with HCC progression 51 . Furthermore, ALDOB has been found to be a binding protein of the S region of the HbsAg 52 . Our data showed that ALDOB expression suppressed in HBV + HCC patients, suggesting a potentially interesting mechanistic linkage between HCC and HBV infection, which might be utilized as therapeutic target.
Summary of regulated proteins in HCC samples
We summarize all differentially expressed proteins in HCC samples including the AFPhigh group and HBV + group (Fig. 6A) . Interestingly, the proteins with increased expression concentrated in three types of pathways: a) production of DNA, mRNA and protein; b)
oncogenic signaling pathways and apoptosis; c) immune response. This suggests enhanced proliferation of tumor cells in the malignant tissues. In contrast, proteins participated in various metabolism pathways were down-regulated, indicating the suppression of metabolic functionality in liver during oncogenesis. Compared to a previous report of HCC tissue proteome using SWATH-MS 16 , our data are acquired in a shorter time frame but identified similar protein alternation. For instance, we also observed malignant tissue displayed increased abundance of glucose-6-phophate dehydrogenase (G6PD) and perilipin 2 (PLIN2), as well as downregulation of formimidoyltransferase cyclodeaminase (FTCD) and phosphoenolpyruvate carboxykinase 2 (PCK2, mitochondrial).
From literature review of all the regulated proteins in Fig. 6A , we identified 16 proteins of clinical relevance to HCC (Fig. 6B ). For instance, the overexpression of PKM2 was more frequently found in cirrhotic liver resulted from HBV infection, and ALDOB, whose interaction with HbsAg might be applied as a potential therapeutic target for HBV-related hepatitis or HCC.
We calculated the expression level of these 16 proteins between tumorous and the adjacent nontumorous (named as normal) tissue, as was shown in Fig. 6B , the log10 MS intensity, with the p value for each pair of comparison between normal and tumor. Although this study is not the first to identify the relevance of these proteins to liver cancer, our study further consolidates their roles in HCC tissues, and more importantly, we demonstrate that this PCT-SWATH-based highthroughput methodology allows measurement of clinically relevant proteins from biopsy-level tissue samples.
Conclusion
In 
